Kearns Evan, Chief Legal Officer of Cogent Biosciences, Inc. ($COGT), sold shares on the open market once in the last 365 days for a total of $2.5 million. His most recent sale occurred on December 26, 2025. These sales rank 3,042nd among 11,678 insiders in our database, where the average sale amount is $8.6 million across about 6.4 transactions. Kearns Evan made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 26, 2025 | Cogent Biosciences, Inc. | $COGT | Kearns Evan | Chief Legal Officer | S | Common Stock | 65000 | $38.70 | 109,398.0000 | 142,376,529 | 37.27% | 0.05% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Kearns Evan | Chief Legal Officer | A | Common Stock | 40000 | $0.00 | 40,000.0000 | 142,376,529 | 9999.99% | 0.03% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Kearns Evan | Chief Legal Officer | A | Common Stock | 260000 | $0.00 | 300,000.0000 | 142,376,529 | 650.00% | 0.18% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Kearns Evan | Chief Legal Officer | F | Common Stock | 125602 | $39.45 | 174,398.0000 | 142,376,529 | 41.87% | 0.09% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Kearns Evan | Chief Legal Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 142,376,529 | 9999.99% | 0.04% |
| Jan. 23, 2025 | Cogent Biosciences, Inc. | $COGT | Kearns Evan | Chief Legal Officer | A | Stock Option (Right to Buy) | 230000 | $0.00 | 230,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Cogent Biosciences, Inc. | $COGT | Kearns Evan | Chief Legal Officer | A | Stock Option (Right to Buy) | 255000 | $0.00 | 255,000.0000 | 0 | 9999.99% | 0.00% |